Posted in | News | Automotive Materials

Reducing Adhesion Failures in the Automotive Industry

Henniker Plasma, a leading manufacturer of plasma surface treatment equipment, presents the latest and most reliable solutions for enhancing adhesion performance in the automotive sector.

Plasma pre-treatment is a crucial step for improving the quality and durability of automotive assemblies and components. It enhances the adhesion and compatibility of different materials that are used for encapsulation, printing, or painting processes. By applying plasma to the surface of low-energy materials, it removes contaminants and creates functional groups that increase the surface energy and reactivity. This results in a stronger and more uniform bond between the materials, reducing the risk of failure and defects. 

Batch plasma treatment of automotive parts.

In the automotive industry, the utilization of advanced treatments like atmospheric and vacuum plasma holds immense potential in significantly improving the adhesion properties of bond lines and electrical connection posts of components prior to their assembly with other parts.

Read our full Press Release here for more information on reducing adhesion failures in the automotive industry: Click here to download the full Press Release

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Henniker Plasma. (2023, June 20). Reducing Adhesion Failures in the Automotive Industry. AZoM. Retrieved on April 28, 2024 from https://www.azom.com/news.aspx?newsID=61500.

  • MLA

    Henniker Plasma. "Reducing Adhesion Failures in the Automotive Industry". AZoM. 28 April 2024. <https://www.azom.com/news.aspx?newsID=61500>.

  • Chicago

    Henniker Plasma. "Reducing Adhesion Failures in the Automotive Industry". AZoM. https://www.azom.com/news.aspx?newsID=61500. (accessed April 28, 2024).

  • Harvard

    Henniker Plasma. 2023. Reducing Adhesion Failures in the Automotive Industry. AZoM, viewed 28 April 2024, https://www.azom.com/news.aspx?newsID=61500.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.